TTrialPathMatch Me to Trials
← Back to trials
RecruitingCerebral VasospasmAneurysmal Subarachnoid Hemorrhage (aSAH)

Registry on NeVa VS for CerebraL VAsospasm ManagemenT in Post SAH PatiEnts

Eligible age

22+ yrs

Accepts

All genders

Locations

13 states

Healthy volunteers

No

See if you qualify for this study

Answer a few quick questions about your location and health. Takes about a minute.

Check my eligibility →

About this study

A multi-center, observational registry study intended to assess the HDE-approved NeVa VS cerebral artery dilation device in patients with symptomatic cerebral vasospasm caused by aneurysmal subarachnoid hemorrhage (aSAH)

Sponsor: Vesalio

You may qualify if…

  • 1. Age ≥22
  • 2. Symptomatic cerebral vasospasm secondary to aneurysmal subarachnoid hemorrhage (aSAH) in the internal carotid artery (ICA), middle cerebral artery (MCA), anterior cerebral artery (ACA), posterior cerebral artery (PCA), or basilar artery (BA)
  • 3. Vessel dilation procedure was performed with the NeVa VS
  • 4. Subject or legal representative is able and willing to give informed consent within 3 days (72 hours) post-index procedure

You may not qualify if…

  • None

Where it's recruiting

California

Burbank · Walnut Creek

Connecticut

New Haven

Florida

Miami

Georgia

Marietta

Illinois

Evanston

Iowa

Iowa City

Kentucky

Lexington

Maine

Portland

Minnesota

Rochester

Pennsylvania

Pittsburgh · Wilkes-Barre

Texas

Harlingen · Houston

Utah

Salt Lake City

Source: ClinicalTrials.gov · NCT06893588 · last updated 2026-05-27

Registry on NeVa VS for CerebraL VAsospasm ManagemenT in Post SAH Pati · TrialPath